Webbför 21 timmar sedan · Shanghai Pharmaceuticals wird voraussichtlich am 29.04.2024 die Bilanz für das jüngste Quartal veröffentlichen, das zum 31.03.2024 abgelaufen ist. 1 … WebbDeveloper Shanghai Pharmaceuticals Holding Class Anti-inflammatories; Antihypertensives Mechanism of Action Renin inhibitors Orphan Drug Status No New Molecular Entity Yes Highest Development Phases Phase III Hypertension Phase II Diabetic nephropathies; Ulcerative colitis Most Recent Events

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. presenta los …

Webb24 feb. 2024 · Company profile for Shanghai Pharmaceuticals Holding Co. Ltd. including key executives, insider trading, ownership, revenue and average growth rates. View detailed 2607.HK description & address. WebbShanghai Pharmaceuticals is a Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and … how do i have my mail forwarded temporarily

Shanghai Pharmaceuticals Holding Co., Ltd (China)

WebbShanghai Pharmaceuticals Holding Co., Ltd. (hereinafter as Shanghai Pharma, SSE stock code 601607 and HKEx stock code 02607) is a large pharmaceutical group to have a dual-listing in the stock ... Webb31 mars 2024 · Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research and development, manufacture, distribution, and retail of pharmaceutical products. The company was founded on January 18, 1994 ... WebbFör 1 dag sedan · Shanghai Pharmaceuticals wird voraussichtlich am 29.04.2024 die Bilanz für das jüngste Quartal veröffentlichen, das zum 31.03.2024 abgelaufen ist.. 1 Analyst erwartet einen Gewinn je Aktie von 0,410 CNY. Im Vorjahresquartal waren 0,440 CNY je Aktie in den Büchern gestanden. how do i heal a leaky gut